Hyosung America Names Chris King as Chief Revenue Officer to Drive Company Growth
DALLAS–(BUSINESS WIRE)–Hyosung America, the North American leader in ATM and payments technology, has promoted Chris King to Chief Revenue Officer. In... Read more.
AM Best Affirms Credit Ratings of Austral Participações S.A. and Its Subsidiaries
MEXICO CITY–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings... Read more.
KBRA Assigns Preliminary Ratings to RFS Asset Securitization V LLC, Series 2025-1 Notes
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to notes issued RFS Asset Securitization V LLC (the “Issuer”).... Read more.
Empire State Realty Trust Announces Dividend for Second Quarter 2025
NEW YORK–(BUSINESS WIRE)–Empire State Realty Trust, Inc. (NYSE: ESRT) (the “Company”), today announced that its Board of Directors has declared a... Read more.
BRIDGE INVESTMENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bridge Investment Group Holdings Inc. – BRDG
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. – GLYC
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”)... Read more.
BioRewards Plasma Services and Alpha-1 Plasma Holdings Launch $100M Expansion Plan to Revolutionize Plasma Collection
NEW YORK–(BUSINESS WIRE)–#BiotechStartup—BioRewards Plasma Services (“BioRewards”), a next-generation plasma collection company, has officially... Read more.
Flowserve Announces Results of 2025 Annual Meeting of Shareholders and Quarterly Dividend
DALLAS–(BUSINESS WIRE)–Flowserve Corp. (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, has... Read more.
Delaware District Court Rules in Favor of Acadia in NUPLAZID® (pimavanserin) Formulation Patent Litigation
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. District Court for the District of Delaware ruled... Read more.
KBRA Assigns Preliminary Ratings to Benchmark 2025-V15
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA is pleased to announce the assignment of preliminary ratings to 14 classes of Benchmark 2025-V15,... Read more.